Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA warns of increased suicide risk with common antidepressants, especially in young patients.
The FDA has issued a warning about a "strong increased risk" associated with the use of sertraline, citalopram, and fluoxetine, three commonly prescribed antidepressants.
The alert highlights potential serious side effects, including heightened risks of suicidal thoughts and behaviors, particularly in younger patients.
Health officials urge healthcare providers and patients to monitor for adverse reactions and reassess treatment plans when necessary.
The warning underscores the importance of careful use and ongoing evaluation of these medications.
3 Articles
La FDA advierte del aumento del riesgo de suicidio con antidepresivos comunes, especialmente en pacientes jóvenes.